The underlying mechanism that might partly be the facilitation of spontaneous platelet aggregation by EPO used to treat anemia and its interaction with blood coagulation factors, both leading to tendency of thrombosis [23,24]. The gene discussed is EPO; the disease is anemia (phenotype).